JAK2 and atherosclerosis: METTL3 reduces the stability of janus kinase 2 (JAK2) mRNA via the reader IGF2BP1 in human umbilical vein endothelial cells, thereby inhibiting the JAK2/STAT3 signaling pathway and suppressing oxidized low-density lipoprotein-induced angiogenesis, which holds therapeutic significance for atherosclerosis [201].